Medicine
Amitriptyline and Chlordiazepoxide 14 mg/5 mg tablet
Amitriptyline and Chlordiazepoxide 14 mg/5 mg tablet is a generic prescription medicine for oral use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F). Store in a dry place.
Key facts
- Active ingredient (INN)
- Amitriptyline and Chlordiazepoxide
- Brand
- Sold under the generic name
- Strength
- 14 mg/5 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 500 tablets
- Manufacturer
- Mylan Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F). Store in a dry place.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Schedule CIV
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 10 December 1986
- Identifiers
- RxCUI 856769, 856792DailyMed set ID 66a756f2-ac77-451c-a19a-08896d73b15cNDC 0378-0211Application ANDA071297
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, film coated in 1 bottle, plastic | 0378-0211-01 | Mylan Pharmaceuticals | 10 December 1986 |
| 500 tablet, film coated in 1 bottle, plastic | 0378-0211-05 | Mylan Pharmaceuticals | 10 December 1986 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 23 December 1977 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Amitriptyline and Chlordiazepoxide
Clinical summary
Amitriptyline and Chlordiazepoxide is a fixed-dose combination of a benzodiazepine and a tricyclic antidepressant indicated for the treatment of patients with moderate to severe depression associated with moderate to severe anxiety. MedsAcross supplies Amitriptyline and Chlordiazepoxide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Amitriptyline and ChlordiazepoxideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Chlordiazepoxide and Amitriptyline Hydrochloride prescribing information (Mylan Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Amitriptyline and Chlordiazepoxide 14 mg/5 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.